Citius Oncology doubles share reserve to 30M under 2024 equity plan; issues 360K warrants

CITIUS ONCOLOGY, INC.

Board approved amendment to 2024 Omnibus Stock Incentive Plan, increasing authorized shares from 15M to 30M.
Issued warrants to purchase 360K shares of common stock at $2.1875, exercisable March 10, 2026, expiring 2031.
Warrants issued in private placement under Section 4(a)(2) to a financial advisor.
No other changes were made to the 2024 Plan besides the share increase.

item 3.02item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.